Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time kill kinetics and postantibiotic effect

Clinical Microbiology and Infection

Volumn 4, Issue 4, 1998, Pages 186-198

  Boswell, F J ^a   Andrews, J M ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

HMR 3004; Ketolide; Postantibiotic effect; Time kill kinetics

Indexed keywords

HMR 3004; KETOLIDE; MACROLIDE; NEW DRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTEROIDES FRAGILIS; DOSE TIME EFFECT RELATION; ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PHARMACODYNAMICS; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANIMALIA; BACTEROIDES FRAGILIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0031923067     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00667.x     Document Type: Article

References (12)

1. Agouridas C, Benedetti Y, Denis A, et al. Ketolides, a new distinct semi-synthetic class of macrohdes [abstract F164]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL. Washington DC: American Society for Microbiology, 1994: 227.
2. Agouridas C, Benedetti Y, Denis A, Le Martret O, Chantot JF. Ketolides: a new distinct class of macrolide antibacterials - synthesis and structural characteristics of RU 004 [abstract F157]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington DC: American Society of Microbiology, 1995: 140.
3. Agouridas C, Bonnefoy A, Chantot JF. In vitro antibacterial activity of UR 004, a novel ketolide highly active against respiratory pathogens [abstract F158]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington DC: American Society for Microbiology, 1995: 140.
4. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents; tentative guidelines M26-T. Villanova, Pennsylvania. NCCLS, 1992.
5. Craig WA, Gudmundsson S. Postantibiotic effect. In Lorian V, ed. Antibiotics in laboratory medicine 3rd edn. Williams and Wilkins: Baltimore MD, 1991: 403-31.
6. Lambert HP, O'Grady FW. Macrolides. In: Antibiotic and chemotherapy, 6th edn. New York: Churchill Livingstone, 1992: 168-79.
7. Working Party of the British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27: (suppl D): 22-30.
8. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg 1938; 38: 732-49.
9. Odenholt-Tornqvist I, Lowdin E, Cars O. Postantibiotic effects and postantibioric sub-MIC effects of roxithromycin, clarithromycm. and azithromycin on respiratory tract pathogens Antimicrob Agents Chemother 1995; 39: 221-6.
10. Scaglione F, Dugnani S, Demartini G, Saudelli M, Galmozzi G, Fraschim F. The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin. J Antimicrob Chemother 1993; 32: 507-9.
11. Munckhof WJ, Turnidge JD. Postantibiotic effects of the ketohde HMR 3004 against Gram-positive bacteria [abstract F252]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto. Washington DC: American Society for Microbiology, 1997: 188.
12. Boswell FJ, Andrews JM, Wise R. The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC. J Antimicrob Chemother 1994; 33: 1219-22.